The DOI matches its Crossref record; 653 of the 653 references it cites were found in a registry or an index.
International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 601–653 of 653
Takeuchi, K., Aihara, E., Sasaki, Y., Nomura, Y., & Ise, F. (2006) · PubMed · Cited by 22
Prostaglandin E2 Attenuates Preoptic Expression of GABAA Receptors via EP3 Receptors
Tsuchiya, H., Oka, T., Nakamura, K., Ichikawa, A., Saper, C. B., & Sugimoto, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801359200 · Cited by 22
Spinal mechanism of standard analgesics: Evaluation using mouse models of allodynia
Tsukamoto, M., Kiso, T., Shimoshige, Y., Aoki, T., & Matsuoka, N. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.025 · Cited by 22
Cesare, A. D., Piccolo, P. D., Zacchetti, D., & Grohovaz, F. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6262-9 · Cited by 22
Presynaptic Prostaglandin E2EP1-Receptor Facilitation of Cerebral Nitrergic Neurogenic Vasodilation
Jadhav, V. R., Jabre, A., Chen, M., & Lee, T. J.-F. (2008) · Stroke · doi:10.1161/strokeaha.108.516104 · Cited by 22
Lo, R. K. H., Wise, H. M., & Wong, Y. H. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.05.001 · Cited by 21
Olson, D. M. (2005) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2005.06.004 · Cited by 21
Osborne, N. N., Li, G., Ji, D., da Costa, B. L. A., Fawcett, R. J., Kang, K. D., & Rittenhouse, K. D. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3185 · Cited by 21
Decreased MAPK- and PGE2-dependent IL-11 production in Giα2−/− colonic myofibroblasts
Hoang, B., Trinh, A. T., & Edwards, R. A. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00307.2006 · Cited by 21
Identification and optimization of novel 1,3,4-oxadiazole EP1 receptor antagonists
Hall, A., Brown, S. H., Chowdhury, A., Giblin, G. M. P., Gibson, M., Healy, M. P., Livermore, D. G., Wilson, R. J. M., Naylor, A., Rawlings, D. A., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.06.014 · Cited by 20
Involvement of prostaglandin F2α receptor in ATP-induced mechanical allodynia
Kunori, S., Matsumura, S., Mabuchi, T., Tatsumi, S., Sugimoto, Y., Minami, T., & Ito, S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.069 · Cited by 19
Xu, W., Chou, C.-L., Israel, D. D., Hutchinson, A. J., & Regan, J. W. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.102 · Cited by 19
Recent Progress in Work on PGD2 Antagonists for Drugs Targeting Allergic Diseases
Mitsumori, S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382864 · Cited by 19
Kurihara, Y., Endo, H., & Kondo, H. (2001) · Inflammation Research · doi:10.1007/s000110050716 · Cited by 19
Miyatake, S., Manabe-Kawaguchi, H., Watanabe, K., Hori, S., Aikawa, N., & Fukuda, K. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318145ae2e · Cited by 19
Prostaglandin I2 Plays a Key Role in Zymosan-Induced Mouse Pleurisy
Yuhki, K., Ushikubi, F., Naraba, H., Ueno, A., Kato, H., Kojima, F., Narumiya, S., Sugimoto, Y., Matsushita, M., & Oh‐ishi, S. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134494 · Cited by 19
Self-citationPark, D., Baek, K., Lee, J., Park, Y.-K., Kim, J.-H., Kim, J.-R., & Baek, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.119 · Cited by 18
Prostaglandin E receptor subtype EP4 agonist protects cochleae against noise-induced trauma
Hori, R., Nakagawa, T., Sugimoto, Y., et al. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.014 · Cited by 18
HIF‐1α regulates hypoxia‐induced EP1 expression in osteoblastic cells
Genetos, D. C., Lee, C. M., Wong, A., & Yellowley, C. E. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22119 · Cited by 18
The Gq and G12 Families of Heterotrimeric G Proteins Report Functional Selectivity
Zhang, L., Brass, L. F., & Manning, D. R. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050906 · Cited by 18
Mir, F., & Le Breton, G. C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00482-08 · Cited by 18
Increased severity of renal impairment in nephritic mice lacking the EP1 receptor
Rahal, S. S., McVeigh, L. I., Zhang, Y., Guan, Y., Breyer, M. D., & Kennedy, C. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-029 · Cited by 17
Konger, R. L., Billings, S. D., Prall, N. C., Katona, T. M., DaSilva‐Arnold, S. C., Kennedy, C., Badve, S., Perkins, S. M., & LaCelle, P. T. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.05.025 · Cited by 16
Aguirre, S. A., Huang, W., Prasanna, G., & Jessen, B. A. (2009) · Toxicologic Pathology · doi:10.1177/0192623309351724 · Cited by 16
Myocardial ischemia-mediated excitatory reflexes: a new function for thromboxane A 2 ?
Fu, L., Phan, A., & Longhurst, J. C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00790.2008 · Cited by 16
Denniss, S. G., & Rush, J. W. E. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00933.2008 · Cited by 16
Anti-inflammatory effect of prostanoids in mouse and rat skin: evidence for a role of EP3-receptors.
Ahluwalia, A., & Perretti, M. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38645-3 · Cited by 16
Yamaguchi, T., Kubota, T., Watanabe, S., & Yamamoto, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02151.x · Cited by 15
Chollet, A., Tos, E. G., & Cirillo, R. (2007) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-7-s1-s16 · Cited by 15
Prostanoid receptors in human uterine myocytes: the effect of reproductive state and stretch
Sooranna, S. R., Grigsby, P. L., Myatt, L., Bennett, P. R., & Johnson, M. R. (2005) · Molecular Human Reproduction · doi:10.1093/molehr/gah228 · Cited by 15
Smid, S. D., & Svensson, K. M. (2008) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.12.004 · Cited by 14
Prostaglandin E2 reduces extracellular ATP-induced migration in cultured rat microglia
Nagano, T., Kimura, S. H., & Takemura, M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.018 · Cited by 14
Zhuge, X., Arai, H., Xu, Y. Y., Murayama, T., Kobayashi, T., Narumiya, S., Kita, T., & Yokode, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.121 · Cited by 14
Self-citationTommasini, I., Cerioni, L., Palomba, L., & Cantoni, O. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5637 · Cited by 14
Brügger, N., Kim, N. N., Araldi, G. L., Traish, A. M., & Palmer, S. S. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00676.x · Cited by 13
Hutchinson, A. J., Coons, S. C., Chou, C.-L., Xu, W., Stamer, W. D., Woodward, D. F., & Regan, J. W. (2010) · Current Eye Research · doi:10.3109/02713680903581021 · Cited by 13
Self-citationRoy, S. J., Parent, A. V., Gallant, M. A., de Brum-Fernandes, A. J., Staňková, J., & Parent, J. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.12.022 · Cited by 13
Nakagawa, T., Minami, M., Katsumata, S., Ienaga, Y., & Satoh, M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb17223.x · Cited by 13
Saito, M., Tanaka, H., Sasaki, M., Kurose, H., & Nakahata, N. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.09.006 · Cited by 12
GR 63799X, an EP3 receptor agonist, induced S phase arrest and 3T6 fibroblast growth inhibition
Sánchez, T., & Moreno, J. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.040 · Cited by 12
Zhang, L., Bastepe, M., Jüppner, H., & Ruan, K. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.06.023 · Cited by 12
Optimization of sulfonamide derivatives as highly selective EP1 receptor antagonists
Naganawa, A., Matsui, T., Ima, M., Yoshida, K., Tsuruta, H., Yamamoto, S., Yamamoto, H., Okada, H., Maruyama, T., Nakai, H., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.08.001 · Cited by 11
In vivo reopening of the neonatal ductus arteriosus by a prostanoid EP4-receptor agonist in the rat
Momma, K., Toyoshima, K., Takeuchi, D., Imamura, S., & Nakanishi, T. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.04.006 · Cited by 11
Sugimoto, M., Arai, I., Futaki, N., Hashimoto, Y., Sakurai, T., Honma, Y., & Nakaike, S. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.080 · Cited by 10
Brescia, M., Rokosz, L. L., Cole, A. G., Stauffer, T. M., Lehrach, J. M., Auld, D. S., Henderson, I. M., & Webb, M. L. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.025 · Cited by 9
Colocalization of prostaglandin F2α receptor FP and prostaglandin F synthase-I in the spinal cord
Suzuki-Yamamoto, T., Toida, K., Sugimoto, Y., & Ishimura, K. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800543-jlr200 · Cited by 8
Doheny, H. C., O’Reilly, M., Sexton, D. J., & Morrison, J. J. (2007) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-5-10 · Cited by 8
Schwann cells express IP prostanoid receptors coupled to an elevation in intracellular cyclic AMP
Muja, N., Nelson, J. K., & DeVries, G. H. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21221 · Cited by 7
Perkins, W. E., Burton, E. G., Tsai, B. S., Collins, P. W., Casler, J. J., Gasiecki, A. F., Bauer, R. F., Jones, P. H., & Gaginella, T. S. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20442-6 · Cited by 7
Prostaglandin F2α negatively regulates bone resorption in murine osteoclast development
Kamon, M., Fujita, D., Goto, N., Amano, H., & Sakamoto, K. (2008) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.06.002 · Cited by 6
Gastrointestinal cytoprotection by prostaglandin E and EP receptor subtypes
Takeuchi, K., Kato, S., & Tanaka, A. (2001) · Folia Pharmacologica Japonica · doi:10.1254/fpj.117.274 · Cited by 5
Terashima, S., Nishio, H., Ogura, M., Honda, M., & Takeuchi, K. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.11.014 · Cited by 4
Prostaglandin FP Receptors Do Not Contribute to 24-hour Intraocular Pressure Variation in Mice
Crowston, J. G., Morris, C. A., Lindsey, J. D., & Weinreb, R. N. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0516 · Cited by 4
Cited by
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Sitbon, O., Channick, R., Chin, K. M., Frey, A., Gaine, S., Galiè, N., Ghofrani, H.-A., Hoeper, M. M., Lang, I. M., Preiss, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503184 · Cited by 1,060
General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation
Yam, M. F., Loh, Y. C., Tan, C. S., Khadijah Adam, S., Abdul Manan, N., & Basir, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082164 · Cited by 652
Illuminating G-Protein-Coupling Selectivity of GPCRs
Inoue, A., Raimondi, F., Kadji, F. M. N., Singh, G., Kishi, T., Uwamizu, A., Ono, Y., Shinjo, Y., Ishida, S., Arang, N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.044 · Cited by 638
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Enzymes of the Cyclooxygenase Pathways of Prostanoid Biosynthesis
Smith, W. L., Urade, Y., & Jakobsson, P.-J. (2011) · Chemical Reviews · doi:10.1021/cr2002992 · Cited by 503
Metadata
- Authors
- Woodward, D. F., Jones, R. L., & Narumiya, S.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 63
- Issue
- 3
- Pages
- 471-538
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2111015948
- Cited by
- 443
- References
- 653
- FWCI
- 25.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.